Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions. (2020)
Attributed to:
the roleDefining of IL-1B in breast cancer bone metastasis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jbo.2020.100317
PubMed Identifier: 32995253
Publication URI: http://europepmc.org/abstract/MED/32995253
Type: Journal Article/Review
Volume: 25
Parent Publication: Journal of bone oncology
ISSN: 2212-1366